Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126937971 | 12693797 | 1 | I | 20160726 | 20160817 | 20160829 | 20160829 | EXP | FR-SA-2016SA153397 | AVENTIS | 68.00 | YR | E | F | Y | 0.00000 | 20160829 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126937971 | 12693797 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | Y | U | 20839 | |||||||||
| 126937971 | 12693797 | 2 | C | TENORMIN | ATENOLOL | 1 | IN THE MORNING | 0 | 50 | MG | QD | ||||||||
| 126937971 | 12693797 | 3 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | 0 | 10 | MG | QD | |||||||||
| 126937971 | 12693797 | 4 | C | NATISPRAY | NITROGLYCERIN | 1 | 0 | .3 | MG | ||||||||||
| 126937971 | 12693797 | 5 | C | LASILIX | FUROSEMIDE | 1 | 500 ON THE DAYS WITHOUT DIALYSIS | 0 | QD | ||||||||||
| 126937971 | 12693797 | 6 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | IN EVENING | 0 | 5 | MG | QD | ||||||||
| 126937971 | 12693797 | 7 | C | INEXIUM | ESOMEPRAZOLE | 1 | IN EVENING | 0 | 40 | MG | QD | ||||||||
| 126937971 | 12693797 | 8 | C | LEXOMIL | BROMAZEPAM | 1 | IN EVENING | 0 | .5 | DF | TABLET | QD | |||||||
| 126937971 | 12693797 | 9 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | IN MORNING | 0 | 150 | UG | QD | ||||||||
| 126937971 | 12693797 | 10 | C | RENAGEL | SEVELAMER HYDROCHLORIDE | 1 | IN NOON AND EVENING | 0 | 2 | DF | CAPSULE | BID | |||||||
| 126937971 | 12693797 | 11 | C | CACIT | CALCIUMVITAMIN D | 1 | 1000MG | 0 | 2 | DF | QD | ||||||||
| 126937971 | 12693797 | 12 | C | LANTUS | INSULIN GLARGINE | 1 | IN MORNING | 0 | 28 | IU | QD | ||||||||
| 126937971 | 12693797 | 13 | C | APIDRA | INSULIN GLULISINE | 1 | MORNING, NOON AND EVENING | 0 | 10 | IU | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126937971 | 12693797 | 1 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126937971 | 12693797 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126937971 | 12693797 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126937971 | 12693797 | 1 | 20160726 | 0 |